PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Status
- RECRUITING
- Phase
- PHASE2
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
- Status
- COMPLETED
- Phase
- PHASE1
mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
9-ING-41 in Pediatric Patients With Refractory Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Status
- RECRUITING
- Phase
- PHASE3
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
- Status
- RECRUITING
- Phase
- NA
Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.
- Status
- UNKNOWN
- Phase
- PHASE2
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2